WSO - January 2024 - 38

38
International Journal of Stroke 19(1)
13. Page PS, Khattar NK, White AC, et al. Intra-arterial thrombolysis
for acute central retinal artery occlusion: a systematic
review and meta-analysis. Front Neurol 2018; 9: 76.
14. Schrag M, Youn T, Schindler J, Kirshner H and Greer D.
Intravenous fibrinolytic therapy in central retinal artery occlusion
a patient-level meta-analysis. JAMA Neurol 2015; 72:
1148-1154.
15. Mac Grory B, Nackenoff A, Poli S, et al. Intravenous fibrinolysis
for central retinal artery occlusion: a cohort study and
updated patient-level meta-analysis. Stroke 2020; 51: 2018-
2025.
16. Huang L, Wang Y and Zhang R. Efficacy and safety of intraarterial
thrombolysis in patients with central retinal artery
occlusion: a systematic review and meta-analysis. Graefes
Archive Clin Exp Ophthalmol 2022; 261: 103-113.
17. Huang L, Wang Y and Zhang R. Intravenous thrombolysis
in patients with central retinal artery occlusion: a systematic
review and meta-analysis. J Neurol 2022; 269: 1825-1833.
18. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA
2020 statement: an updated guideline for reporting systematic
reviews. Syst Rev 2021; 10: n71.
19. Guise JM, Butler ME, Chang C, et al. AHRQ series on complex
intervention systematic reviews-paper 6: PRISMA-CI
extension statement and checklist. J Clin Epidemiol 2017; 90:
43-50.
20. Stewart LA, Clarke M, Rovers M, et al. Preferred reporting
items for a systematic review and meta-analysis of individual
participant data: the PRISMA-IPD statement. JAMA 2015;
313: 1657-1665.
21. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of
observational studies in epidemiology: a proposal for reporting.
JAMA 2000; 283: 2008-2012, http://jama.jamanetwork.
com/article.aspx?doi=10.1001/jama.283.15.2008
22. Kim J, Jung S, Park KH, Woo SJ and Jung C. Cerebral angiographic
features of central retinal artery occlusion patients
treated with intra-arterial thrombolysis. J Neurointerv Surg
2021; 14: 772-778.
23. Ko SJ, Shin IC, Kim DW, Choi SS and Yang YS. Safety and
efficacy of selective intra-arterial thrombolysis for central retinal
artery occlusion. Korean J Ophthalmol 2021; 35: 261-271.
24. Cho S, il Kim JH and Cho NC. The effect of intra-arterial
thrombolysis in retinal artery occlusion: case series and literature
review. J Korean Ophthalmol Soc 2020; 61: 1442-1449.
25. Lange C, Feltgen N, Junker B, Schulze-Bonsel K and Bach
M. Resolving the clinical acuity categories " hand motion "
and " counting fingers " using the Freiburg visual acuity test
(FrACT). Graefes Arch Clin Exp Ophthalmol 2009; 247: 137-
142.
26. Morgan RL, Thayer KA, Santesso N, et al. Evaluation of
the risk of bias in non-randomized studies of interventions
(ROBINS-I) and the " target experiment " concept in studies of
exposures: rationale and preliminary instrument development.
Environ Int 2018; 120: 382-387, http://www.sciencedirect.
com/science/article/pii/S0160412017321967
27. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool
for assessing risk of bias in non-randomised studies of interventions.
BMJ 2016; 355: i4919.
28. Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for
case reports: explanation and elaboration document. J Clin
Epidemiol 2017; 89: 218-235.
International Journal of Stroke, 19(1)
29. Kreiliger G. Statistical assessment and adjustment of publication
bias in the cochrane database of systematic reviews.
Doctoral Dissertation, University of Zurich, Zurich, 2019.
30. Duval S and Tweedie R. Trim and fill: a simple funnel-plotbased
method of testing and adjusting for publication bias in
meta-analysis. Biometrics 2000; 56: 455-463.
31. Doi SAR and Thalib L. A quality-effects model for meta-analysis.
Epidemiology 2008; 19: 94-100.
32. Chaudhary D, Anyaehie M, Demiraj F, et al. Comparison of
long-term outcomes and associated factors between younger
and older rural ischemic stroke patients. J Clin Med 2022; 11:
1430.
33. Morris SB and DeShon RP. Combining effect size estimates
in meta-analysis with repeated measures and independentgroups
designs. Psychol Methods 2002; 7: 105-125.
34. Gibbons RD, Hedeker DR and Davis JM. Estimation of effect
size from a series of experiments involving paired comparisons.
J Educ Stat 1993; 18: 271-279.
35. Annonier P, Bénichou C, Flament J and Bronner A. Place de la
fibrinolyse dans le traitement des oblitérations artérielles rétiniennes:
discussion de cinq observations. Bull Soc Ophtalmol
Fr 1988; 88: 1167-1171.
36. Barth H, Stein H, Fasse A and Mehdorn HM. Intrazerebrale
blutung nach systemischer thrombolyse bei patienten mit
verschluss der a. centralis retinae bericht über 2 fälle.
Ophthalmologe 1996; 93: 739-744.
37. Chan W, Flowers AM, Meyer BI, Bruce BB, Newman NJ and
Biousse V. Acute central retinal artery occlusion seen within
24 hours at a tertiary institution. J Stroke Cerebrovasc Dis
2021; 30: 105988.
38. Derieux L, Guyomard JL, Catier A, et al. [Fibrinolysis in
the treatment of the amaurosis fugax: a case report]. J Fr
Ophtalmol 2003; 26: 507-509.
39. Padolecchia R, Puglioli M, Ragone MC, Romani A and
Collavoli PL. Superselective intraarterial fibrinolysis in central
retinal artery occlusion. AJNR Am J Neuroradiol 1999;
20: 565-567.
40. Zhao X, Meng X and Ji X. Treatment of central retinal artery
occlusion by thrombolysis via super-selective ophthalmic
artery catheterization. Chinese Journal of Ocular Fundus
Diseases 1996; 32: 445-447.
41. Agarwal N, Gala NB, Baumrind B, et al. Endovascular
management of central retinal arterial occlusion. Vasc
Endovascular Surg 2016; 50: 579-581.
42. Bonnin N, Thomas V, Gabrillargues J and Bacin F. Fibrinolyse
intra-artérielle in situ chez une patiente monophtalme atteinte
d'occlusion d'artère centrale de rétine. J Fr Ophtalmol 2009;
32: 415-419.
43. Tsai FY, Wadley D, Angle JF, Alfieri K and Byars S.
Superselective ophthalmic angiography for diagnostic and
therapeutic use. AJNR Am J Neuroradiol 1990; 11: 1203-
1204.
44. Tagawa M, Sugiu K, Tokunaga K, et al. [Local intraarterial
fibrinolysis in central retinal artery occlusion: case report]. No
Shinkei Geka 2005; 33: 619-623.
45. Zhizhong M, Baomin L, Hongliang D, et al. Ophthalmic
artery ultraselective thrombolysis for central retinal artery
obstruction. Chin J Ophthalmol 1996; 32: 445-447.
46. Mach R and Procházka J. Trombolýza okluze centrální retinální
arterie alteplázou. Čes a Slov Oftai 2008; 64: 245-248.
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.283.15.2008 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.283.15.2008 http://www.sciencedirect.com/science/article/pii/S0160412017321967 http://www.sciencedirect.com/science/article/pii/S0160412017321967

WSO - January 2024

Table of Contents for the Digital Edition of WSO - January 2024

Content
WSO - January 2024 - Cover1
WSO - January 2024 - Cover2
WSO - January 2024 - 1
WSO - January 2024 - Content
WSO - January 2024 - 3
WSO - January 2024 - 4
WSO - January 2024 - 5
WSO - January 2024 - 6
WSO - January 2024 - 7
WSO - January 2024 - 8
WSO - January 2024 - 9
WSO - January 2024 - 10
WSO - January 2024 - 11
WSO - January 2024 - 12
WSO - January 2024 - 13
WSO - January 2024 - 14
WSO - January 2024 - 15
WSO - January 2024 - 16
WSO - January 2024 - 17
WSO - January 2024 - 18
WSO - January 2024 - 19
WSO - January 2024 - 20
WSO - January 2024 - 21
WSO - January 2024 - 22
WSO - January 2024 - 23
WSO - January 2024 - 24
WSO - January 2024 - 25
WSO - January 2024 - 26
WSO - January 2024 - 27
WSO - January 2024 - 28
WSO - January 2024 - 29
WSO - January 2024 - 30
WSO - January 2024 - 31
WSO - January 2024 - 32
WSO - January 2024 - 33
WSO - January 2024 - 34
WSO - January 2024 - 35
WSO - January 2024 - 36
WSO - January 2024 - 37
WSO - January 2024 - 38
WSO - January 2024 - 39
WSO - January 2024 - 40
WSO - January 2024 - 41
WSO - January 2024 - 42
WSO - January 2024 - 43
WSO - January 2024 - 44
WSO - January 2024 - 45
WSO - January 2024 - 46
WSO - January 2024 - 47
WSO - January 2024 - 48
WSO - January 2024 - 49
WSO - January 2024 - 50
WSO - January 2024 - 51
WSO - January 2024 - 52
WSO - January 2024 - 53
WSO - January 2024 - 54
WSO - January 2024 - 55
WSO - January 2024 - 56
WSO - January 2024 - 57
WSO - January 2024 - 58
WSO - January 2024 - 59
WSO - January 2024 - 60
WSO - January 2024 - 61
WSO - January 2024 - 62
WSO - January 2024 - 63
WSO - January 2024 - 64
WSO - January 2024 - 65
WSO - January 2024 - 66
WSO - January 2024 - 67
WSO - January 2024 - 68
WSO - January 2024 - 69
WSO - January 2024 - 70
WSO - January 2024 - 71
WSO - January 2024 - 72
WSO - January 2024 - 73
WSO - January 2024 - 74
WSO - January 2024 - 75
WSO - January 2024 - 76
WSO - January 2024 - 77
WSO - January 2024 - 78
WSO - January 2024 - 79
WSO - January 2024 - 80
WSO - January 2024 - 81
WSO - January 2024 - 82
WSO - January 2024 - 83
WSO - January 2024 - 84
WSO - January 2024 - 85
WSO - January 2024 - 86
WSO - January 2024 - 87
WSO - January 2024 - 88
WSO - January 2024 - 89
WSO - January 2024 - 90
WSO - January 2024 - 91
WSO - January 2024 - 92
WSO - January 2024 - 93
WSO - January 2024 - 94
WSO - January 2024 - 95
WSO - January 2024 - 96
WSO - January 2024 - 97
WSO - January 2024 - 98
WSO - January 2024 - 99
WSO - January 2024 - 100
WSO - January 2024 - 101
WSO - January 2024 - 102
WSO - January 2024 - 103
WSO - January 2024 - 104
WSO - January 2024 - 105
WSO - January 2024 - 106
WSO - January 2024 - 107
WSO - January 2024 - 108
WSO - January 2024 - 109
WSO - January 2024 - 110
WSO - January 2024 - 111
WSO - January 2024 - 112
WSO - January 2024 - 113
WSO - January 2024 - 114
WSO - January 2024 - 115
WSO - January 2024 - 116
WSO - January 2024 - 117
WSO - January 2024 - 118
WSO - January 2024 - 119
WSO - January 2024 - 120
WSO - January 2024 - 121
WSO - January 2024 - 122
WSO - January 2024 - 123
WSO - January 2024 - 124
WSO - January 2024 - 125
WSO - January 2024 - 126
WSO - January 2024 - Cover3
WSO - January 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com